BLU Plunges On RELIEF Data, FDA Places CLLS' Trial On Hold, IMMU Hits New High, OTIC Music To Ears

Today's Daily Dose brings you news about BLU'S disappointing results from RELIEF trial, FDA hold on CLLS' trial, positive results from Immunomedics' confirmatory trial of Trodelvy, OBSV's phase III studies of Yselty in women with heavy menstrual bleeding due to uterine fibroids, OTIC's tinnitus study results, and clinical progress of REGN's anti-viral cocktail In treatment/prevention of COVID-19.